| Brian Nelson, | |
|
208 17th Ave Se, Puyallup, WA 98372-4515 | |
| (253) 840-1999 | |
| Not Available |
| Full Name | Brian Nelson |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 43 Years |
| Location | 208 17th Ave Se, Puyallup, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316360639 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD00020208 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cascade Hernia And Surgical Solutions Ps | 3577663665 | 4 |
News Archive
Orexigen® Therapeutics, Inc. announced that results from its COR-I trial of Contrave® were published online today in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration. Results show that patients taking Contrave were two to three times more likely to lose at least 5% or 10% of their body weight compared to those taking placebo, on both an intent-to-treat (ITT) and completers basis.
Phenomena related to near-death experiences, immortality in virtual reality, and genes that prevent a species of freshwater hydra from aging are among the first research proposals funded by The Immortality Project at the University of California, Riverside.
Scientists from INRA in collaboration with a Chinese team found that the gut microbiota[1] of individuals with liver cirrhosis differ notably from healthy individuals', showing a high proportion of oral bacteria.
As Americans struggle to become more physically active, simple programs that provide feedback and motivation can play a crucial role in getting people off to a good start, according to a study of the July issue of Health Psychology.
Scientists have found evidence that the reduced effectiveness of breast screening in women in their 40s is mainly due to their tumours being harder to detect, rather than because they grow faster.Previous research has suggested that breast screening is less effective in women in their 40s than in older women.Two reasons have been identified for this - firstly, that younger women tend to have denser breast tissue which makes it harder to detect tumours on a mammogram; and secondly, because younger women's tumours tend to grow more quickly.
› Verified 1 days ago
| Entity Name | Cascade Hernia And Surgical Solutions Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174725402 PECOS PAC ID: 3577663665 Enrollment ID: O20070702000417 |
News Archive
Orexigen® Therapeutics, Inc. announced that results from its COR-I trial of Contrave® were published online today in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration. Results show that patients taking Contrave were two to three times more likely to lose at least 5% or 10% of their body weight compared to those taking placebo, on both an intent-to-treat (ITT) and completers basis.
Phenomena related to near-death experiences, immortality in virtual reality, and genes that prevent a species of freshwater hydra from aging are among the first research proposals funded by The Immortality Project at the University of California, Riverside.
Scientists from INRA in collaboration with a Chinese team found that the gut microbiota[1] of individuals with liver cirrhosis differ notably from healthy individuals', showing a high proportion of oral bacteria.
As Americans struggle to become more physically active, simple programs that provide feedback and motivation can play a crucial role in getting people off to a good start, according to a study of the July issue of Health Psychology.
Scientists have found evidence that the reduced effectiveness of breast screening in women in their 40s is mainly due to their tumours being harder to detect, rather than because they grow faster.Previous research has suggested that breast screening is less effective in women in their 40s than in older women.Two reasons have been identified for this - firstly, that younger women tend to have denser breast tissue which makes it harder to detect tumours on a mammogram; and secondly, because younger women's tumours tend to grow more quickly.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Nelson, 208 17th Ave Se, Puyallup, WA 98372-4515 Ph: (253) 840-1999 | Brian Nelson, 208 17th Ave Se, Puyallup, WA 98372-4515 Ph: (253) 840-1999 |
News Archive
Orexigen® Therapeutics, Inc. announced that results from its COR-I trial of Contrave® were published online today in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration. Results show that patients taking Contrave were two to three times more likely to lose at least 5% or 10% of their body weight compared to those taking placebo, on both an intent-to-treat (ITT) and completers basis.
Phenomena related to near-death experiences, immortality in virtual reality, and genes that prevent a species of freshwater hydra from aging are among the first research proposals funded by The Immortality Project at the University of California, Riverside.
Scientists from INRA in collaboration with a Chinese team found that the gut microbiota[1] of individuals with liver cirrhosis differ notably from healthy individuals', showing a high proportion of oral bacteria.
As Americans struggle to become more physically active, simple programs that provide feedback and motivation can play a crucial role in getting people off to a good start, according to a study of the July issue of Health Psychology.
Scientists have found evidence that the reduced effectiveness of breast screening in women in their 40s is mainly due to their tumours being harder to detect, rather than because they grow faster.Previous research has suggested that breast screening is less effective in women in their 40s than in older women.Two reasons have been identified for this - firstly, that younger women tend to have denser breast tissue which makes it harder to detect tumours on a mammogram; and secondly, because younger women's tumours tend to grow more quickly.
› Verified 1 days ago
Dr. Cholwoo Anthony Kim, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1519 3rd St Se, Ste 230, Puyallup, WA 98372 Phone: 253-841-9640 Fax: 253-841-7645 | |
Dr. Douglas R. King, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1519 3rd St Se, Ste 230, Puyallup, WA 98372 Phone: 253-841-9640 Fax: 253-841-7645 | |
Dr. Kenneth A. Feucht, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1519 3rd St Se, Ste 230, Puyallup, WA 98372 Phone: 253-445-1844 Fax: 253-841-9701 | |
Dr. Chia J. Chung, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 105 27th Ave Se, Puyallup, WA 98374 Phone: 253-848-8110 Fax: 253-845-3561 | |
Miles Mcbride Dale, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1519 3rd St Se Ste 230, Puyallup, WA 98372 Phone: 253-841-9640 Fax: 253-841-7645 | |
Robert Charles Wright, MD FACS Surgery Medicare: Accepting Medicare Assignments Practice Location: 208 17th Ave Se, Suite 201, Puyallup, WA 98372 Phone: 253-840-1999 Fax: 253-445-4125 |